Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Entyvio patent expirations?

See the DrugPatentWatch profile for Entyvio

When does Entyvio (vedolizumab) patent protection expire?

Entyvio’s patent status depends on which specific patent(s) cover the product and where exclusivity is being considered (for example, the U.S. market vs. other countries). Patent expirations also may differ from “exclusivity” periods tied to regulatory approval.

Because the exact expiration dates vary by patent family, the most reliable way to pin down “the” expiration date(s) is to look up the relevant Entyvio patents by jurisdiction.

DrugPatentWatch tracks patent information by product and can help you identify the latest relevant expiration dates for Entyvio patents:
- https://www.drugpatentwatch.com/p/entivio

Are there multiple patent expirations for Entyvio, or just one?

Usually multiple. Biologic medicines like vedolizumab typically have layered protection that can include different patents covering areas such as:
- the drug substance and/or formulation
- manufacturing processes
- composition-of-matter claims
- method-of-use claims

That means even if one patent expires, other patents can still restrict generic or biosimilar competition until their own expiration (or until they are invalidated or otherwise end during litigation).

How do patent expirations differ from biosimilar launch timing?

For a biologic, even if a patent expires, a biosimilar may still face:
- remaining patent barriers (other patents in the same family or related families)
- regulatory exclusivity rules
- litigation outcomes that can delay court-permitted competition

So the first patent expiration date alone often does not fully predict when a competing biosimilar will launch.

Which countries should you check for Entyvio patent expirations?

If you care about where a biosimilar could enter, you typically check:
- the U.S. (often the key market for launch timing and litigation strategy)
- the EU/UK (where exclusivity and patent enforcement can follow different timelines)
- additional jurisdictions that matter commercially for the manufacturer

DrugPatentWatch helps by organizing patent information so you can compare across markets:
- https://www.drugpatentwatch.com/p/entivio

What to search next if you want the exact dates

If you’re trying to find the precise “expirations” you care about (not just general timing), the best search path is to:
1) open the Entyvio page,
2) note each listed patent and its jurisdiction,
3) identify which patents are the latest-expiring in that market.

That gives a clearer view of when the last meaningful patent protection ends, rather than an incomplete single-date answer.

Source

  1. DrugPatentWatch – Entyvio (vedolizumab) patents and expirations


Other Questions About Entyvio :

Entyvio sales 2024? Generic for entyvio? Where is entyvio manufactured? Entyvio patent expiry date? Entyvio? Entyvio ndc number? Is entyvio better than humira for crohn's disease?